Misa Togi

7PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCancer diagnosisMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2023
Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells.

Terutsugu Koya, Kenichi Yoshida, Misa Togi

|Oct 27, 2022
The Detection of Immunity against WT1 and SMAD4<sup>P130L</sup> of EpCAM<sup>+</sup> Cancer Cells in Malignant Pleural Effusion.

Terutsugu Koya, Yo Niida, Misa Togi

|Aug 12, 2022
Different In Vitro-Generated MUTZ-3-Derived Dendritic Cell Types Secrete Dexosomes with Distinct Phenotypes and Antigen Presentation Potencies.

Takuya Sakamoto, Terutsugu Koya, Misa Togi

|Jun 02, 2021
Quality Verification with a Cluster-Controlled Manufacturing System to Generate Monocyte-Derived Dendritic Cells.

Haruhiko Kawaguchi, Takuya Sakamoto, Terutsugu Koya

|Dec 30, 2020
Interferon-α-Induced Dendritic Cells Generated with Human Platelet Lysate Exhibit Elevated Antigen Presenting Ability to Cytotoxic T Lymphocytes.

Ippei Date, Terutsugu Koya, Takuya Sakamoto

|Apr 02, 2020
Dendritic Cells Pre-Pulsed with Wilms' Tumor 1 in Optimized Culture for Cancer Vaccination.

Terutsugu Koya, Ippei Date, Haruhiko Kawaguchi

Pageof 2

Frequent Collaborators

6 joint publications

Takuya Sakamoto

5 joint publications

Shigetaka Shimodaira

3 joint publications

Shigeo Koido

2 joint publications

Yasuhito Ishigaki